A new cancer drug candidate developed by Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

Organizations that delay systematic AI deployment risk being left behind by competitors who have already mastered the transition from experimentation to execution.

Ultimately, the most effective AI adoption strategies recognize that humans fundamentally drive the implementation of ...

Opinion: Lidiya Mishchenko and Pooya Shoghi explain how to bridge a gap preventing successful patent claims to protect new ...

For over a decade, researchers have considered boson sampling—a quantum computing protocol involving light particles—as a key ...

Studying a decision in archerfish reveals an impressive potential of learning capacities and cognitive aspects that are unexpected for decisions made at reflex speed.